← Compare landing
Aldeyra Therapeutics vs ProSciento
Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.
| Category | Aldeyra Therapeutics | ProSciento |
|---|---|---|
| Summary | Biopharmaceutical company developing immunomodulatory therapies for immune-mediated ocular and systemic diseases, with late-stage clinical candidates targeting dry eye disease, allergic conjunctivitis, and retinal conditions. | Specialized CRO focused on metabolic diseases (obesity, diabetes, MASLD/MASH, cardiovascular, chronic kidney disease) with two decades of expertise, a nationwide registry of 180,000+ participants, and full-service clinical development capabilities from Phase 1 through Phase 3. |
| Services |
|
|
| Modalities |
| Data not yet provided. |
| Indications |
|
|
| Phases |
|
|
| Sourcing models | Data not yet provided. |
|
| Locations | Data not yet provided. |
|
| Certifications | Data not yet provided. | Data not yet provided. |
Find similar companies
Markdown mirror: /compare/aldeyra/prosciento.md